The recall includes more than 1,600 devices distributed from October 2006 to June 2021. Medtronic's HVAD system has already been associated with multiple issues, including a separate recall in 2021.
A volunteer from the PREVENT-19 study receives a COVID-19 vaccine. Image courtesy of Novavax.
The committee's approval comes days after the FDA shared details on a small number of trial participants who developed myocarditis or pericarditis after receiving the vaccine.
Charles D. Fraser, Jr., MD, executive director of the new Institute for Cardiovascular Health in Austin, Texas, discusses the facility's new, state-of-the-art cardiology program.
Brian Ghoshhajra, MD, division chief, cardiovascular imaging, Massachusetts General Hospital, explains what specialized training is needed to perform coronary computed tomography angiography (CCTA) as interest rapidly rises in this field.
The Society for Cardiovascular Angiography and Interventions (SCAI) has announced its late-breaking study presentations at its 2022 Scientific Sessions.
Memorial Regional Hospital in Hollywood, Florida, recently became just the fourth hospital in the United States to earn an Advanced Heart Failure Accreditation from the American College of Cardiology.
One of the newest technologies to be discussed at SCAI 2022 was a no-implant interatrial shunt device to treat heart failure patients with preserved and reduced ejection fraction (HFpEF and HFrEF), which showed safety and feasibility with a promising efficacy signal through six months.
The key interventional cardiology takeaways from sessions presented at the Society for Cardiovascular Angiography and Interventions (SCAI) 2022 annual meeting.
